A. Azzedine

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Bruno Chauffert, F. Mornex, F. Bonnetain et al. · Annals of Oncology · 2008 · 685 citations

Intensive Induction Chemoradiotherapy, Surgical Oncology, Pancreatic Cancer +10

Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study

Rosine Guimbaud, Christophe Louvet, Pauline Ries et al. · Journal of Clinical Oncology · 2014 · 256 citations

Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma

Thierry Façon, J. Jenifer Florence Mary, Jean‐Luc Harousseau et al. · Journal of Clinical Oncology · 2006 · 195 citations

Elderly Patients, Immunology, Pharmacotherapy +18

Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial

Michel Ducreux, David Malka, Jean Mendiboure et al. · The Lancet Oncology · 2011 · 151 citations

Gastrointestinal Oncology, Medicine, Ffcd 2000–05 +8

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)

Thomas Aparicio, Sandrine Lavau‐Denès, Jean–Marc Phelip et al. · Annals of Oncology · 2015 · 104 citations · Full text

Elderly Patients, Gastrointestinal Oncology, Medicine +8